Skip to main navigation Skip to search Skip to main content

Late onset of autoimmune hepatitis in myasthenia gravis

  • Shamez Ladhani
  • , John Schofield
  • , George Bird*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

A 35-year-old caucasian female presented with acute onset bilateral ptosis while driving, followed by weakness of the facial and upper limb muscles. A diagnosis of myasthenia gravis (MG) was made on the basis of clinical examination, and confirmed by electromyography, high titres of anti- acetylcholine receptor antibodies and a positive response to pyridostigmine. She underwent thymectomy and her symptoms resolved. She presented again 16 years later (age 51) with tiredness, jaundice and a biochemical hepatitis. Serological and histopathological investigations were in keeping with autoimmune chronic hepatitis and there was a satisfactory response to oral prednisolone. She was unable to tolerate the conventional high dose steroid induction due to a relapse of her MG but subsequently entered remission with intermediate dose regime of prednisolone. Despite a recognised association between both autoimmune hepatitis (AIH) and MG with other autoimmune diseases, a literature search showed the combination of these two conditions to be extremely rare with only one adequately documented previous report.

Original languageEnglish
Pages (from-to)259-263
Number of pages5
JournalInternational Hepatology Communications
Volume13
Issue number3
DOIs
Publication statusPublished - Feb 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chronic hepatitis
  • Human leukocyte antigens
  • Interface hepatitis

Fingerprint

Dive into the research topics of 'Late onset of autoimmune hepatitis in myasthenia gravis'. Together they form a unique fingerprint.

Cite this